This study is to determine the efficacy (how well the drug works), safety, and side effects of the study medication compared to placebo in the treatment of the negative symptoms of schizophrenia in adults.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
180
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Birmingham Psychiatry Pharmaceutical Studies, Inc.
Birmingham, Alabama, United States
IPR
Cerritos, California, United States
Synergy Clinical Research
Chula Vista, California, United States
Optimum Health Services
La Mesa, California, United States
Sierra Vista Hospital
Sacramento, California, United States
Clinical Innovations
Santa Ana, California, United States
Research Strategies
Torrance, California, United States
University of Colorado
Denver, Colorado, United States
Psychiatric Institute of Washington
Washington D.C., District of Columbia, United States
Berma Research Group
Hialeah, Florida, United States
...and 19 more locations